Follow Us:
Thursday, August 18, 2022

New research: Those who had Covid-19 may need only one vaccine dose

The study provides more insight on the underlying immunobiology of mRNA vaccines, which could help shape future vaccine strategies.

By: Express News Service | New Delhi |
Updated: April 21, 2021 6:43:47 am
Sign at a vaccination centre in California. The Pfizer and Moderna vaccines both use the mRNA platform. (Reuters)

People who have recovered from Covid-19 had a robust antibody response after the first mRNA vaccine dose, but little immune benefit after the second dose, according to new research from the Penn Institute of Immunology. The study has been published in Science Immunology.

The researchers said their findings suggest that only a single vaccine dose may be needed to produce a sufficient antibody response. The team found that those who did not have Covid-19 did not have a full immune response until after receiving their second vaccine dose, reinforcing the importance of completing the two recommended doses for achieving strong levels of immunity.

Newsletter | Click to get the day’s best explainers in your inbox

The study provides more insight on the underlying immunobiology of mRNA vaccines, which could help shape future vaccine strategies.

Subscriber Only Stories
Delhi Confidential: Kerala football club stuck in Tashkent, S-G Tushar Me...Premium
Explained: The ‘developed country’ goalPremium
An Expert Explains: Why a stable Kenya is in the interest of Africa &...Premium
With fund & engineers, Taliban help rebuild gurdwara hit by Islamic S...Premium

“These results are encouraging for both short- and long-term vaccine efficacy, and this adds to our understanding of the mRNA vaccine immune response through the analysis of memory B cells,” senior author E John Wherry, director of the Penn Institute of Immunology, said in a statement issued by the University of Pennsylvania.

The human immune response to vaccines and infections results in two major outcomes — the production of antibodies that provide rapid immunity, and the creation of memory B cells that assist in long-term immunity. This study investigated how memory B cell responses differ after vaccination in people who previously experienced infection, compared to those who have not had Covid-19.

“Previous Covid-19 mRNA vaccine studies on vaccinated individuals have focused on antibodies more than memory B cells. Memory B cells are a strong predictor of future antibody responses, which is why it’s vital to measure B cell responses to these vaccines. This effort to examine memory B cells is important for understanding long-term protection and the ability to respond to variants,” Wherry said.

Source: University of Pennsylvania

📣 Join our Telegram channel (The Indian Express) for the latest news and updates

For all the latest Explained News, download Indian Express App.

  • Newsguard
  • The Indian Express website has been rated GREEN for its credibility and trustworthiness by Newsguard, a global service that rates news sources for their journalistic standards.
  • Newsguard
First published on: 21-04-2021 at 04:30:53 am
0 Comment(s) *
* The moderation of comments is automated and not cleared manually by

Featured Stories